The PRECIS-2 tool seems not to be useful to discriminate the degree of pragmatism of medicine masked trials from that of open-label trials
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00228-020-03030-8.pdf
Reference50 articles.
1. Patsopoulos NA (2011) A pragmatic view on pragmatic trials. Dialogues Clin Neurosci 13:217–224
2. Dal-Ré R, Rosendaal F (2018) Efficacy and effectiveness: the wrong use of different terms. Eur J Intern Med 54:e17–e18
3. Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M (2015) The PRECIS-2 tool: designing trials that are fit for purpose. BMJ 350:h2147
4. Sepehrvand N, Alemayehu W, Das D, Gupta AK, Gouda P, Ghimire A et al (2019) Trends in the explanatory or pragmatic nature of cardiovascular clinical trials over 2 decades. JAMA Cardiol 4:1122–1128
5. Devos F, Foissac F, Bouazza N, Ancel PY, Tréluyer JM, Chappuy H (2019) Study characteristics impacted the pragmatism of randomized controlled trial published in nursing: a meta-epidemiological study. J Clin Epidemiol 116:18–25
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Using PRECIS-2 in Chinese herbal medicine randomized controlled trials for irritable bowel syndrome: A methodological exploration based on literature;Integrative Medicine Research;2024-09
2. The need for more pragmatic trials in glaucoma research;European Journal of Ophthalmology;2024-04-11
3. Lack of pragmatic attitude of self-labelled pragmatic trials on manual therapy: A methodological review;2023-10-29
4. An analysis of published trials found that current use of pragmatic trial labels is uninformative;Journal of Clinical Epidemiology;2022-11
5. Generalizability of randomized controlled trials in primary health care: Applying the PRECIS‐2 tool on published protocols;Journal of Evaluation in Clinical Practice;2022-09-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3